Vialox (Pentapeptide-3V) Topical (200mg)

Vialox (Pentapeptide-3V) Topical (200mg) is a lyophilized research peptide synthesized, purified, and lyophilized in the USA. Each production batch is purified by repeated rounds of reverse-phase HPLC and identity-confirmed by mass spectrometry.

Vialox (Pentapeptide-3V) Topical (200mg) is a cosmetic-research peptide evaluated in formulations for its signaling effects on skin-related cell models.

Studies of Vialox (Pentapeptide-3V) Topical (200mg) typically focus on collagen-related or matrix-associated endpoints in dermal cell cultures.

Researchers using Vialox (Pentapeptide-3V) Topical (200mg) validate peptide stability in topical vehicle systems before experimental application.

Each vial contains lyophilized peptide at the labeled quantity, and wholesale orders are packed in boxes of ten vials at a single per-vial price.

Quality assurance: every batch is purified by reversed-phase high-performance liquid chromatography and identity-confirmed by mass spectrometry, with purity above 99%. Lot-specific certificates of analysis are available on request. Store lyophilized vials at -20°C, protected from light and moisture; reconstitute with bacteriostatic water immediately before use and avoid repeated freeze-thaw cycles. For in-vitro laboratory research use only —not for human or veterinary use.

Research & Literature

The following peer-reviewed studies and reference documents are commonly consulted by researchers working with Vialox (Pentapeptide-3V) Topical (200mg). Summaries are provided for orientation only and reflect the cited sources.

Quantum Chemical, Spectroscopic and In Silico (Molecular Docking, Molecular Dynamic and ADME) Studies on Anti-Aging Pentapeptide-3 (Vialox)^[1] —This computational study applied quantum chemical, spectroscopic, and in silico methods, including molecular docking, molecular dynamics, and ADME analysis, to investigate the anti-aging pentapeptide-3 (Vialox). The authors analyzed the peptide's structure and drug-likeness properties. The findings supported the potential of Vialox as an anti-wrinkle neuropeptide mimetic. (International Journal of Quantum Chemistry 2025)

Cosmeceutical Peptides in the Framework of Sustainable Wellness Economy^[2] —This review discussed short anti-wrinkle peptides that act at the neuromuscular junction, the class to which pentapeptide-3 (Vialox) belongs. The authors examined how such peptides modulate neurotransmitter release to reduce expression lines. The review indicated that neuropeptide-mimetic peptides are widely used in cosmetic anti-aging products. (Frontiers in Chemistry 2020)

Role of topical peptides in preventing or treating aged skin^[3] —This review evaluated the role of topical peptides in preventing or treating aged skin, including neurotransmitter-inhibitor peptides such as pentapeptide-3. The authors assessed the clinical efficacy evidence for these ingredients. The review suggested that topical peptides can contribute to the management of skin aging, although evidence varies by peptide class. (International Journal of Cosmetic Science 2009)

References

1. Akhan D, Bicak B, Kecel Gunduz S, Akalin E. "Quantum Chemical, Spectroscopic and In Silico (Molecular Docking, Molecular Dynamic and ADME) Studies on Anti-Aging Pentapeptide-3 (Vialox)." International Journal of Quantum Chemistry. 2025. onlinelibrary.wiley.com/doi/full/10.1002/qua.70085
2. Errante F, Ledwoń P, Latajka R, Rovero P, Papini AM. "Cosmeceutical Peptides in the Framework of Sustainable Wellness Economy." Frontiers in Chemistry. 2020. public-pages-files-2025.frontiersin.org/journals/chemistry/articles/10.3389/fchem.202—
3. Gorouhi F, Maibach HI. "Role of topical peptides in preventing or treating aged skin." International Journal of Cosmetic Science. 2009. pubmed.ncbi.nlm.nih.gov/19570099/

All products are supplied as lyophilized powder for in-vitro laboratory research use only and are not for human or veterinary use.